Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Current Deferred Revenue data on record, last reported at $2.9 million in Q4 2012.

  • For Q4 2012, Current Deferred Revenue rose 54.81% year-over-year to $2.9 million; the TTM value through Dec 2012 reached $2.9 million, up 54.81%, while the annual FY2012 figure was $1.6 million, 10.45% down from the prior year.
  • Current Deferred Revenue reached $2.9 million in Q4 2012 per SNOA's latest filing, roughly flat from $2.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.9 million in Q3 2012 and bottomed at $1.6 million in Q1 2012.